Lyell Immunopharma, Inc. (LYEL) Insider Trading
0 insider purchases in the last 7 days
No open market insider purchases at Lyell Immunopharma, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track LYEL on your watchlist.
Start for FreeAbout Lyell Immunopharma, Inc. Insider Trading
2 insiders at Lyell Immunopharma, Inc. (LYEL) have purchased stock in the past 90 days, totaling $25.0M across 2 transactions (976,180 shares).
The most recent purchase was by 10%+ Owner ARCH Venture Partners IX, LLC on March 6, 2026 — a $12.5M buy of 488,090 shares at $25.61, bringing his total holdings to 1,426,528 shares.
Insiders who purchased: ARCH Venture Partners IX, LLC (10%+ Owner, 1 buy totaling $12.5M); ARCH Venture Fund XIII, L.P. (10%+ Owner, 1 buy totaling $12.5M).
This insider buying is notable given that LYEL had no recorded open market purchases in the nine months before that.
Track LYEL insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.